| Literature DB >> 31126084 |
Elena Badetti1, Loris Calgaro2, Laura Falchi3, Alessandro Bonetto4, Cinzia Bettiol5, Benedetta Leonetti6,7, Emmanuele Ambrosi8,9, Elisabetta Zendri10, Antonio Marcomini11.
Abstract
The increasing concern about antibiotic-resistance has led to the search for alternative antimicrobial agents. In this effort, different metal oxide nanomaterials are currently under investigation, in order to assess their effectiveness, safety and mode of action. This study focused on CuO nanoparticles (CuO NPs) and was aimed at evaluating how the properties and the antimicrobial activity of these nanomaterials may be affected by the interaction with ligands present in biological and environmental media. Ligands can attach to the surface of particles and/or contribute to their dissolution through ligand-assisted ion release and the formation of complexes with copper ions. Eight natural amino acids (L-Arg, L-Asp, L-Glu, L-Cys, L-Val, L-Leu, L-Phe, L-Tyr) were chosen as model molecules to investigate these interactions and the toxicity of the obtained materials against the Gram-positive bacterium Staphylococcus epidermidis ATCC 35984. A different behavior from pristine CuO NPs was observed, depending on the aminoacidic side chain. These results were supported by physico-chemical and colloidal characterization carried out by means of Fourier-Transform Infrared spectroscopy (FTIR), Differential Scanning Calorimetry (DSC) and Thermo-Gravimetric Analysis (TGA), Inductively Coupled Plasma Mass Spectrometry (ICP-MS) and light scattering techniques (Dynamic Light Scattering (DLS), Electrophoretic Light Scattering (ELS) and Centrifugal Separation Analysis (CSA).Entities:
Keywords: amino acids; antimicrobial activity; copper oxide nanoparticles
Year: 2019 PMID: 31126084 PMCID: PMC6566567 DOI: 10.3390/nano9050792
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Figure 1Chemical structure of the selected amino acids grouped according to the chemical characteristics of the side chain.
Inductively Coupled Plasma Mass Spectrometry (ICP-MS) Parameters.
| Component/Parameter | Type/Value/Mode |
|---|---|
| Nebulizer | Meinhard quartz microconcentric |
| Spray Chamber | Quartz cyclonic |
| Triple Cone Interface Material | Nickel/Aluminum |
| Plasma Gas Flow | 18 L/min |
| Auxiliary Gas Flow | 1.2 L/min |
| Nebulizer Gas Flow | 0.96–1 L/min |
| Sample Uptake Rate | 200–250 µL/min |
| RF Power | 1600 W |
| Isotope | 63Cu |
Figure 2Fourier Transform Infrared spectroscopy (FTIR) spectra of (a) CuO nanoparticles (CuO NPs) pristine and treated with Arg and Val; (b) free Cys, Cu-Cys complex and CuO NPs treated with Cys; (c) free Glu, Cu-Glu complex and CuO NPs treated with Glu (d) free Asp, Cu-Asp complex and CuO NPs treated with Asp; (e) free Leu, Cu-Leu complex and CuO NPs treated with Leu; (f) Cu-Phe complex, CuO NPs treated with Phe, Cu-Tyr complex and CuO NPs treated with Tyr.
Figure 3(a) Differential Scanning Calorimetry (DSC) and (b) Thermo-Gravimetric Analysis (TGA) analysis of CuO NPs and CuO NPs with the different amino acids.
Total copper content in pristine and treated CuO NPs measured by Inductively Coupled Plasma Mass Spectrometry (ICP-MS) and calculated on the basis of TG analysis, and total copper content in Cu-amino acid complexes measured by ICP-MS.
| NPs | Complexes | ||
|---|---|---|---|
| ICP-MS Cu (%) | TGA Cu (%) | ICP-MS Cu (%) | |
| CuO | 74.6 ± 0.6 | 78 | - |
| Val | 74.4 ± 0.5 | 77 | 20.9 ± 0.5 |
| Arg | 73.0 ± 0.3 | 80 | 12.1 ± 0.7 |
| Cys | 53.0 ± 0.3 | 55 | 20.3 ± 0.6 |
| Asp | 23.5 ± 0.3 | 29 | 27.0 ± 0.6 |
| Glu | 31.5 ± 0.5 | 32 | 15.6 ± 0.5 |
| Leu | 32.9 ± 0.4 | 30 | 21.7 ± 1.6 |
| Phe | 28.7 ± 0.2 | 27 | 19.8 ± 0.5 |
| Tyr | 26.5 ± 0.7 | 31 | 13.6 ± 0.7 |
Hydrodynamic size, zeta potential (ξ) and sedimentation velocity values of pristine CuO NPs and treated with amino acids, dispersed in ultrapure water.
| NPs | Hydrodynamic Size (nm) | ξ (mV) | Sedimentation Velocity (μm/s) |
|---|---|---|---|
| CuO | 340 ± 206 | 15.4 ± 0.6 | 0.03 ± 0.01 |
| CuO + Val | 839 ± 182 | 13.1 ± 1.0 | 0.04 ± 0.01 |
| CuO + Arg | 518 ± 103 | 7.8 ± 0.9 | 0.07 ± 0.01 |
| CuO + Cys | 2630 ± 1031 | −4.3 ± 0.8 | 0.26 ± 0.01 |
| CuO + Asp | 2714 ± 1371 | −0.3 ± 0.7 | 0.33 ± 0.01 |
| CuO + Glu | 2084 ± 1053 | 1.3 ± 1.7 | 0.22 ± 0.03 |
| CuO + Leu | 2803 ± 1522 | −8.1 ± 1.9 | 0.34 ± 0.03 |
| CuO + Phe | 1491 ± 895 | −4.0 ± 0.5 | 0.22 ± 0.01 |
| CuO + Tyr | 4205 ± 1009 | −6.5 ± 1.4 | 0.28 ± 0.01 |
Figure 4Viability (%) of the Gram-positive bacterium Staphylococcus epidermidis ATCC 35984 vs. copper concentration in (a) pristine CuO NPs, CuO NPs treated with Val and CuO NPs treated Arg; (b) CuSO4, Cu-Val complex and Cu-Arg complex; (c) pristine CuO NPs, CuO NPs treated with Cys and Cu-Cys complex; (d) pristine CuO NPs, CuO NPs treated with Glu and Cu-Glu complex; (e) pristine CuO NPs, CuO NPs treated with Asp and Cu-Asp complex; (f) pristine CuO NPs, CuO NPs treated with Leu and Cu-Leu complex; (g) pristine CuO NPs, CuO NPs treated with Phe and Cu-Phe complex and (h) pristine CuO NPs, CuO NPs treated with Tyr and Cu-Try complex.
Minimal Inhibitory Concentration (MIC) values of the different materials tested. All the concentrations refer to Cu content measured by ICP-MS (see Table 2).
| Materials | MIC (μg Cu/mL) | Materials | MIC (μg Cu/mL) |
|---|---|---|---|
| CuO NPs | 94 | CuSO4 | 99 |
| CuO NPs + Val | 93 | Cu-Val complex | 104 |
| CuO NPs + Arg | 91 | Cu-Arg complex | >60 |
| CuO NPs + Cys | 265 | Cu-Cys complex | 101 |
| CuO NPs + Asp | 120 | Cu-Asp complex | >135 |
| CuO NPs + Glu | 39 | Cu-Glu complex | 78 |
| CuO NPs + Leu | 165 | Cu-Leu complex | 54 |
| CuO NPs + Phe | >143 | Cu-Phe complex | >99 |
| CuO NPs + Tyr | 135 | Cu-Tyr complex | 68 |